REGISTRATION
United Kingdom (Grimsby), 2024
PRODUCER
No specific laboratory indicated
PRODUCT OPTIONS
222 mg, 444 mg (capsules & powder)
SUBSIDIARY BRANDS
Lincoln Health
INDEPENDENT CERTIFICATE OF ANALYSIS
No independent CoA, data from in-house, sister brand testing
Ablabs Elixer Limited
Full Brand & Product Review
Overall Rating: 3 / 10
2026.04.08
Overview
Ablabs Elixer Limited is a UK-registered company selling fenbendazole capsules and powder through its own website and Amazon marketplaces in the UK, Canada, UAE, and Italy. It entered the market in 2025. Its UK registration is genuine, its directors are publicly named, and its payment options are standard. Those are the positives. Everything that follows is a problem.
Background: Corporate Identity
Ablabs Elixer Limited is registered at Companies House, number 16118668, incorporated 4 December 2024. Registered address: Unit 1 GPC, Estate Road, Grimsby, DN31 2TB. Directors Jack Benjamin Kirwin (born January 1986) and Abby Robinson (born December 1990) are listed as persons with significant control under UK identity verification requirements.
The Sister Brand: Lincoln Health Ltd
Three months after Ablabs was incorporated, a second company appeared at the same industrial estate. Lincoln Health Ltd (Companies House no. 16261507) was registered on 19 February 2025 at Unit 2 GPC, Estate Road, Grimsby, one unit from Ablabs at Unit 1. Lincoln Health's two directors share the exact same dates of birth as Ablabs' two directors: January 1986 and December 1990. The product range is identical: fenbendazole, ivermectin, and methylene blue.
Lincoln Health products appear alongside Ablabs on Amazon without any disclosed connection between them. Neither brand mentions the other on any consumer-facing page. A buyer comparing these two brands as competing fenbendazole suppliers is comparing the same two people's output against itself, with no way of knowing that from any storefront either brand operates.
The Certificate of Analysis
When asked for quality documentation, Ablabs provided a Certificate of Analysis. Read carefully, it contradicts the company's own marketing on the most important claim it makes
The certifying entity is the sister company. The COA bears two logos: Ablabs on the left, Lincoln Health on the right. It is signed by Dr. Emily Carter, Lead Analyst, Lincoln Health Laboratory. Lincoln Health Ltd is not an independent accredited laboratory. It is a company incorporated by the same two directors, registered in the adjacent unit of the same building. Calling this third-party certification requires redefining what third-party means.
The document uses the word "internal." The certification statement reads: "This batch meets all internal quality control standards for laboratory use."
Every Ablabs Amazon and storefront listings call this a "third-party laboratory Analysis Report." That is a direct contradiction between the brand's marketing and its own paperwork.
One batch number across three products. Batch FEN-0625-001 covers fenbendazole powder, 222mg capsules, and 444mg capsules simultaneously. These are separate manufacturing processes requiring separate batch records. A single number across all three is consistent with template documentation rather than individual batch testing.
No accreditation, no instrument data, no lab address. A legitimate COA from an independent laboratory includes an accreditation number, the laboratory's physical address, instrument identifiers, and dated analyst credentials. None of these appear. Lincoln Health Laboratory does not appear in any publicly accessible accreditation register.
The documents were sent with visible errors and never corrected. The MSDS included alongside the COA contained black placeholder squares where the molecular formula should appear. These are rendering artifacts from an unreviewed auto-generated template. The document was not corrected, not replaced, and not acknowledged as defective. It arrived in that state and stayed that way.
The HPLC chromatogram was requested and not delivered. The COA states purity was determined by HPLC. When asked whether an HPLC document was available, Ablabs responded: "Hi, I've sent all the documents we provide, hope that helps." The chromatogram was not provided. Without the underlying raw data, the 99.4% purity figure cannot be traced to any actual analytical work.
Criteria Ratings
1. Information Transparency
Rating: 4 / 10
Ablabs discloses its UK registration and named directors. Beyond that, the transparency record is poor. The company claims third-party testing on every product listing and storefront. The COA it provides names its own sister company as the certifying laboratory and uses the word "internal" in the certification statement. No independent laboratory is named anywhere on the website or in any product listing. The gap between what the brand claims and what its documentation shows is not subtle.
2. Label Accuracy
Rating: 1 / 10
Ablabs claims fenbendazole purity above 99%. That claim is supported by a COA certified by a sister company, containing the word "internal" in its own statement, covering three distinct product formats under a single batch number, with no accreditation and delivered with unresolved formatting errors that were never corrected. When asked whether an HPLC document was available to support the stated 99.4% figure, Ablabs confirmed that no further documentation exists beyond what was already sent. The raw analytical data behind the purity claim has no verifiable basis. There is only the claim itself.
3. Product Definition
Rating: 6 / 10
The product is standard. Fenbendazole capsules in 222 mg and 444 mg doses, no listed fillers, plant-based shells.
The compound is correctly identified. No exaggerated claims are made.
This meets baseline expectations, but does not extend beyond them.
4. Manufacturer Traceability
Rating: 1 / 10
Ablabs operates as a UK-registered reseller. Its listed address corresponds to a light industrial estate in Grimsby.
No manufacturing activity is disclosed.
There is no information on where the compound is produced, who manufactures it, or under what conditions.
The company is traceable. The product is not.
5. Availability and Distribution
Rating: 4/ 10
The checkout screenshot clearly shows the issue. A standard international order of 30 x 444 mg capsules priced at €52.95 includes a mandatory shipping fee of €11.95, bringing the total to €64.90. The only available option for international buyers is Express International shipping at €11.95, with a delivery estimate of 2–11 business days.
Payment is handled through two options: PayPal, which redirects the user to an external page, and Bankful, which supports Visa, Mastercard, and American Express. Overall, payment coverage is sufficient.
The main issue lies in cost and distribution.
A €52.95 product effectively becomes a €64.90 purchase for international customers — an increase of about 23%. Many competitors offset this entirely by offering free worldwide shipping. In addition, the 2–11 business day delivery window is relatively broad compared to market standards, where suppliers with warehouses in the US and EU often deliver within 3–5 days domestically at no extra cost.
Ablabs operates from a single warehouse in the UK. For customers outside the UK, this results in higher total cost and less predictable delivery times, making it less competitive compared to alternatives.
On Facebook, the numbers are inconsistent. The page has around 18,000 followers, yet posts typically receive only 5 to 10 likes.
This suggests an engagement rate of roughly 0.03 to 0.05 percent, which is far below what would normally be expected.
Even low-engagement audiences usually generate around 2 to 5 percent interaction.
A page of this size would typically produce hundreds of interactions per post. The gap between follower count and engagement raises serious doubts about the quality of the audience.
6. Public Feedback Patterns
Rating: 2/10
The overall feedback across platforms is not only limited, but in several areas raises concerns about how it is presented.
On Amazon, Ablabs’ fenbendazole product has a 4.1 out of 5 rating based on 36 reviews over the past 12 months. While 69% of these are five-star ratings, 14% are one-star. With such a small sample, this level of negative feedback is significant and cannot be ignored.
Ablabs also has no presence on Trustpilot, which is widely used by competitors as a primary independent review platform.
On the company’s website, the fenbendazole product shows a five-star rating based on 16 reviews.
However, these reviews cannot be opened or verified.
There is no review text, no reviewer information, and no dates. The rating appears only as a static visual element, which makes it impossible to confirm whether it reflects real customer feedback.
The company has also run a campaign encouraging users to create video reviews on TikTok and Instagram in exchange for financial rewards.
Participants are asked to post the content publicly and provide the original files upon request.
This introduces a clear incentive that can influence how reviews are created and presented across platforms.
Taken together, the picture is weak. There is a small and mixed set of Amazon reviews, no Trustpilot presence, unverifiable ratings on the website, unusually low Facebook engagement, and incentivized review activity. This does not provide a clear or fully reliable view of the brand’s reputation.
On the Ablabs website, reviews are hosted through Judge.me, a legitimate Shopify review app but not a neutral platform in the way Trustpilot is.
Merchants using Judge.me can enable review curation, meaning negative reviews can be withheld before any consumer sees them.
Multiple documented cases exist of legitimate negative reviews being removed by merchants without recourse for the reviewer.
On the company’s website, the fenbendazole product shows a five-star rating based on 16 reviews.
However, these reviews cannot be opened or verified.
There is no review text, no reviewer information, and no dates. The rating appears only as a static visual element, which makes it impossible to confirm whether it reflects real customer feedback.
On the Ablabs website, reviews are hosted through Judge.me, a legitimate Shopify review app but not a neutral platform in the way Trustpilot is.
Merchants using Judge.me can enable review curation, meaning negative reviews can be withheld before any consumer sees them.
Multiple documented cases exist of legitimate negative reviews being removed by merchants without recourse for the reviewer.
The company has also run a campaign encouraging users to create video reviews on TikTok and Instagram in exchange for financial rewards.
Participants are asked to post the content publicly and provide the original files upon request.
This introduces a clear incentive that can influence how reviews are created and presented across platforms.
Taken together, the picture is weak. There is a small and mixed set of Amazon reviews, no Trustpilot presence, unverifiable ratings on the website, unusually low Facebook engagement, and incentivized review activity. This does not provide a clear or fully reliable view of the brand’s reputation.